MedicinesFAQ

Neisseria Meningitidis Group Y Polysaccharide Antigen Uses, Dosage, Side Effects and more

Meningococcal group Y polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup Y. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup Y.

Attribute Details
Trade Name Neisseria Meningitidis Group Y Polysaccharide Antigen
Generic Meningococcal polysaccharide vaccine group Y
Meningococcal polysaccharide vaccine group Y Other Names Meningococcal polysaccharide antigen group Y, Neisseria meningitidis group Y capsular polysaccharide antigen, Neisseria meningitidis group Y polysaccharide antigen, A
Type
Groups Approved, Experimental, Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am
   

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.